- ... - 06c1c8ee-6564-46fe-9989-dbf4fbf086fe_1531776

Sets strict timelines for FDA responses (currently 150 days).

The core issue discussed in the SSRN study (ID 1531776) is whether brand-name manufacturers use these filings strategically. 06C1C8EE-6564-46FE-9989-DBF4FBF086FE_1531776 - ...

The Federal Trade Commission (FTC) continues to monitor this area for antitrust violations. While many petitions raise legitimate scientific concerns, the debate remains: how to balance the right to petition the government with the need for competitive, affordable healthcare markets. Sets strict timelines for FDA responses (currently 150 days)

Feature: The Strategy of Delay — Understanding FDA Citizen Petitions In the context of pharmaceuticals

In the complex world of pharmaceutical regulation, the serves as a vital public safety valve. However, as explored in the paper associated with your identifier, this mechanism has also been scrutinized as a potential tool for "gaming" the system to delay the market entry of lower-priced generic drugs. 1. What is a Citizen Petition?

Under FDA regulations, any individual or entity can petition the agency to take (or refrain from taking) a specific administrative action. In the context of pharmaceuticals, these are often used to raise concerns about the safety or bioequivalence of a pending generic drug application (ANDA). 2. The "Sham" Petition Concern